Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adults Condition: Day 1 Initial dose |
Dose: Oral Tablet – 4 tablets Frequency: initially Note: Administer 24 tablets over 3 days; use a 3-day treatment schedule with a total of 6 doses. |
|
Age: Adults Condition: Day 1 Second dose |
Dose: Oral Tablet – 4 tablets Frequency: after 8 hours Note: Administer 24 tablets over 3 days; use a 3-day treatment schedule with a total of 6 doses. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Children |
Dose: Oral Tablet – 4 tablets Frequency: Four tablets initially and 4 tablets again after 8 hours on Day 1; then twice daily (morning and evening) on Days 2 and 3 Duration: 3 days Note: Total of 24 tablets over 6 doses |
|
Age: Children |
Dose: Oral Tablet – 1 tablet Frequency: One tablet initially and again after 8 hours on Day 1; then twice daily (morning and evening) for the next 2 days Duration: 3 days Note: Total of 6 tablets |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: No specific pharmacokinetic studies have been performed in patients with renal impairment. No dose adjustment is necessary in patients with renal impairment is advised. Note: No specific pharmacokinetic studies have been performed in patients with renal impairment. No dose adjustment is necessary in patients with renal impairment is advised. |
Administration
- Take with fatty food
- Complete full course
Side Effect
- Abdominal pain (17%)
- Anorexia (40%)
- Arthralgia (34%)
- Asthenia (38%)
- Chills (23%)
- Dizziness (39%)
- Fatigue (17%)
- Headache (56%)
- Myalgia (32%)
- Nausea (26%)
- Palpitations (18%)
- Pyrexia (25%)
- Sleep disorder (22%)
- Vomiting(17%)
- Anemia (4%)
- Cough (6%)
- Diarrhea (7%)
- Hepatomegaly (9%)
- Malaise (3%)
- Nasopharyngitis (3%)
- Pruritus (4%)
- Rash (3%)
- Splenomegaly (9%)
- Vertigo (3%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Erythromycin, Terfenadine, Procainamide, Quinidine, Disopyramide, Amiodarone, Bretylium, Bepridil, Sotalol, Astemizole, Probucol, Tricyclic Antidepressants (Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram, Venlafaxine, Duloxetine), Phenothiazines
|
May cause QT prolongation, avoid concomitant use
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.